ロード中...
Epidermal growth factor receptor inhibition in lung cancer: the evolving role of individualized therapy
Non-small cell lung cancer (NSCLC) is the major cause of cancer-related deaths in the USA and worldwide. Most patients present with advanced disease, and treatment options for these patients are generally limited to platinum-based chemotherapy and a few targeted therapies. Targeted agents currently...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3387977/ https://ncbi.nlm.nih.gov/pubmed/20127143 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10555-010-9201-z |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|